An 18-year-old man with a history of bipolar disorder, autism spectrum disorder, attention deficit hyperactivity disorder, hypothyroidism and persistent mild asthma was taken by his mother to the emergency department because of altered consciousness.
Her mother also reported fever, nasal congestion and cough for seven days.
Her current medication was 450 mg lithium twice daily, 100 mg clozapine daily and levothyroxine.
On physical examination, the patient was suffering from a mental illness but awake.
He had no acute distress, could answer simple questions, and was oriented.
His vital signs were: respiratory rate 18 r.p.m., temperature 38.5 oC, pulse 120 l.p.m., pressure 120/60, and SpO2 98% in room air.
Pulmonary examination was normal.
The laboratory tests showed a leukocyte count of 11.79 x 103/mm3 with 17% lymphocytes, high creatinine 1.81 mg/dl (grade 1 mg/dl) and lithium concentration 2.60 mmol/L.
The ECG showed sinus tachycardia with a pulse of 107 l.p.m.
A chest X-ray was normal.
A nasopharyngeal swab for SARS-CoV-2 analyzed by RT-PCR was positive.
He was admitted to the pediatric ICU due to infection with COVID-19, acute kidney injury and lithium poisoning.
An aggressive dose of IV saline was administered.
to treat lithium poisoning and acute kidney injury.
She did not undergo hemodialysis.
Her mental status improved.
He received symptomatic treatment for infection with COVID-19.
Her condition improved and she was discharged without further complications on day 11 of hospitalization.
During the hospital evolution, he never presented hypoxemia.
Lithium treatment was interposed with the intention of reintroducing it in a follow-up visit.
